PEIpro Transfection Reagent for Cell and Gene Therapy 2024

PEIpro Transfection Reagent for Cell and Gene Therapy 2024

PEIpro? transcends the ordinary, offering an optimized PEI-based transfection reagent designed for scalable viral vector production in both adherent and suspension systems.

This cutting-edge reagent is not just a facilitator; it is a catalyst for efficiency, reproducibility, and GMP-grade excellence.

Reproducible Excellence: Three Tiers of Quality

One of the hallmarks of PEIpro Transfection Reagent is its commitment to reproducibility. With three quality grades available—PEIpro?, PEIpro?-HQ, and PEIpro?-GMP—equivalent viral vector production yields are guaranteed.

This ensures that the manufacturing process is not just efficient but consistent, laying the foundation for robust and reliable outcomes.

GMP-Grade Availability: Elevating Quality Standards: PEIpro Transfection Reagent

PEIpro? takes pride in its GMP-grade availability, adhering to the stringent guidelines outlined in ICH Q7.

This validated manufacturing process is accompanied by full regulatory documentation, underscoring its commitment to the highest quality standards for active pharmaceutical ingredients (API).

Patient safety is paramount, and PEIpro? ensures that every step aligns with the rigorous requirements of GMP.

Read More

要查看或添加评论,请登录

GeneX India Bioscience Pvt Ltd的更多文章

社区洞察

其他会员也浏览了